The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 09, 2017

Filed:

Jan. 13, 2011
Applicant:

Dipanjan Chowdhury, Chestnut Hill, MA (US);

Inventor:

Dipanjan Chowdhury, Chestnut Hill, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/166 (2006.01); A61K 31/4184 (2006.01); A61K 31/435 (2006.01); A61K 31/502 (2006.01); A61K 31/55 (2006.01); A61K 31/7088 (2006.01); C12Q 1/68 (2006.01);
U.S. Cl.
CPC ...
A61K 31/166 (2013.01); A61K 31/4184 (2013.01); A61K 31/435 (2013.01); A61K 31/502 (2013.01); A61K 31/55 (2013.01); A61K 31/7088 (2013.01); C12Q 1/6886 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/178 (2013.01);
Abstract

The present disclosure provides methods of determining the levels of BRCA1 in a cell, altering the levels of BRCA1 in a cell, determining the likelihood of developing cancer, and determining the prognosis of a patient with cancer using miR-182 and analogs thereof. Importantly, the invention also provides methods of determining whether a patient should be treated with PARP inhibitors, improving PARP therapy in cancer, as well as methods for selecting and improving genotoxic therapies. Also featured are methods of treating patients with cancers based on the expression levels of miR-182. The invention also features compositions comprising miR-182 and analogs thereof, antagomirs of mIR-182 and analogs thereof, in combination with PARP inhibitors and genotoxic agents.


Find Patent Forward Citations

Loading…